(Q35976385)

11 August 2017

1 reference

title

Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases? (English)

1 reference

11 August 2017

1 reference

1

Charles N Serhan

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Expert Opinion on Therapeutic Targets

11 August 2017

published in

1 reference

11 August 2017

volume

8

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

643-652

1 reference

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Regulation of bone mass in mice by the lipoxygenase gene Alox15

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Activation of the fatty acid alpha-dioxygenase pathway during bacterial infection of tobacco leaves. Formation of oxylipins protecting against cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Lipoxins: revelations on resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Lipoxins are potential endogenous antiinflammatory mediators in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Inhibition of 15-lipoxygenase leads to delayed organelle degradation in the reticulocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Simultaneous expression of leukocyte-type 12-lipoxygenase and reticulocyte-type 15-lipoxygenase in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Lipoxins: pro-resolution lipid mediators in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Immunodeficiency diseases caused by defects in phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Points of control in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.6.643

21 January 2018

Identifiers

DOI

10.1517/14728222.8.6.643

1 reference

11 August 2017

1 reference